Amanda M. De Hoedt

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts

Donna P. Ankerst, J. Straubinger, Katharina Selig et al. · European Urology · 2018 · 135 citations · Full text

Medicine, Biostatistics, Urology +14

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer

Nicholas G. Nickols, Ramin Nazarian, Shuang G. Zhao et al. · Prostate Cancer and Prostatic Diseases · 2019 · 96 citations · Full text

Medicine, Molecular Biology, Oncology +17

Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy

Stephen J. Freedland, Voleak Choeurng, Lauren E. Howard et al. · European Urology · 2016 · 80 citations · Full text

Medicine, Oncology, Urology +17

Prostate Specific Antigen Density as a Predictor of Clinically Significant Prostate Cancer When the Prostate Specific Antigen is in the Diagnostic Gray Zone: Defining the Optimum Cutoff Point Stratified by Race and Body Mass Index

Alireza Aminsharifi, Lauren E. Howard, Yuan Wu et al. · The Journal of Urology · 2018 · 75 citations

Medicine, Oncology, Urology +17

Estimated Costs and Long-term Outcomes of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health System

Stephen B. Williams, Lauren E. Howard, Meagan Foster et al. · JAMA Network Open · 2021 · 62 citations · Full text

Medicine, Oncology, Urology +10